|Emitents||Olainfarm, AS (213800WCG52W62ENOP27)|
|Veids||2.2. Iekšējā informācija|
On June 5 JSC Olainfarm organized its Investor Conference Online Webinar. During the webinar the Chairman of Management Board Lauris Macijevskis, Member of the Supervisory Council Karlis Krastins and Investor Relations Advisor Janis Dubrovskis analyzed the financial results of first quarter 2019 and informed about other recent activities within the company.
The recorded webinar is available online: https://bit.ly/2Xq2Q3H, and the presentation, demonstrated during the webinar, is available in the attachment. Methodology for alternative performance indicators is disclosed in Annual report for 2018 (page 20) and in Financial statements for 3 months period ended 31 March 2019 (page 15).
Olainfarm thanks all participants, who joined the webinar, and encourages everybody to follow company’s announcements to get information on the next webinar!
JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company's operations is to produce reliable and effective top -quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 60 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.
Jānis Dubrovskis Investor Relations Advisor of JSC Olainfarm Ph.: +371 29178878 firstname.lastname@example.org